Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.45 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.45 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.45 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12946725 | 1.00 | OPRM1 (0.46) | OPRM1CHRNB2CHRNB4CHRNA4SPHK1 | |
| SCHEMBL9475459 | 1.00 | OPRM1 (0.46) | OPRM1CHRNB2CHRNB4CHRNA4SPHK1 | |
| SCHEMBL7559541 | 1.00 | OPRM1 (0.46) | OPRM1CHRNB2CHRNB4CHRNA4SPHK1 | |
| SCHEMBL11852533 | 1.00 | OPRM1 (0.46) | OPRM1CHRNB2CHRNB4CHRNA4SPHK1 | |
| SCHEMBL1024279 | 1.00 | OPRM1 (0.46) | OPRM1CHRNB2CHRNB4CHRNA4SPHK1 | |
| SCHEMBL12946732 | 1.00 | OPRM1 (0.46) | OPRM1CHRNB2CHRNB4CHRNA4SPHK1 | |
| SCHEMBL3255391 | 1.00 | OPRM1 (0.46) | OPRM1CHRNB2CHRNB4CHRNA4SPHK1 | |
| SCHEMBL11341311 | 1.00 | OPRM1 (0.46) | OPRM1CHRNB2CHRNB4CHRNA4SPHK1 | |
| SCHEMBL20747520 | 1.00 | OPRM1 (0.46) | OPRM1CHRNB2CHRNB4CHRNA4SPHK1 | |
| SCHEMBL9696772 | 1.00 | OPRM1 (0.46) | OPRM1CHRNB2CHRNB4CHRNA4SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109689021-A | Protein hydrolysate | 巴斯夫欧洲公司 | 2019-04-26 | — | — | CN | disclosed |
| CN-109689022-A | Low molecular weight keratin hydrolyzate | 巴斯夫欧洲公司 | 2019-04-26 | — | — | CN | disclosed |
| CN-103835128-B | Method for treating synthetic fiber, method for spinning synthetic fiber, and spun yarn | 竹本油脂株式会社 | 2019-04-02 | — | — | CN | disclosed |
| CN-105263582-B | Comprising oil body, fatty acid, amino acid surfactant and N- methyl-N- acyl glucamides composition | 克拉里安特国际有限公司 | 2018-12-21 | — | — | CN | disclosed |
| CN-104350124-B | From the method for subsurface formations recovery of oil | 巴斯夫欧洲公司 | 2018-02-16 | — | — | CN | disclosed |
| US-9809717-B2 | Antimicrobial-coated medical articles | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-11-07 | — | — | US | disclosed |
| EP-2576471-B1 | ANTIMICROBIAL COATED MEDICAL ARTICLES | 3M INNOVATIVE PROPERTIES CO (US) | 2017-10-25 | — | — | EP | disclosed |
| CN-103254671-B | Antimicrobial coatings | 3M创新有限公司 | 2017-05-03 | — | — | CN | disclosed |
| CN-103003215-B | Antimicrobial coatings | 3M创新有限公司 | 2017-02-15 | — | — | CN | disclosed |
| EP-2576472-B1 | ANTIMICROBIAL COATINGS | 3M INNOVATIVE PROPERTIES CO (US) | 2016-03-23 | — | — | EP | disclosed |
| CN-103835128-A | Method for treating synthetic fiber, method for spinning synthetic fiber, and spun yarn | TAKEMOTO OIL & FAT CO LTD | 2014-06-04 | — | — | CN | disclosed |
| CN-103254671-A | Antimicrobial coatings | 3M INNOVATIVE PROPERTIES CO | 2013-08-21 | — | — | CN | disclosed |
| EP-2576472-A2 | ANTIMICROBIAL COATINGS | 3M Innovative Properties Company (US) | 2013-04-10 | — | — | EP | disclosed |
| EP-2576471-A2 | ANTIMICROBIAL COATED MEDICAL ARTICLES | 3M Innovative Properties Company (US) | 2013-04-10 | — | — | EP | disclosed |
| CN-103003215-A | Antimicrobial coatings | 3M INNOVATIVE PROPERTIES CO | 2013-03-27 | — | — | CN | disclosed |
| US-20120015002-A1 | ANTIMICROBIAL COATINGS | 3M INNOVATIVE PROPERTIES COMPANY | 2012-01-19 | — | — | US | disclosed |
| WO-2011150001-A2 | ANTIMICROBIAL COATINGS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-12-01 | — | — | WO | disclosed |
| WO-2011150103-A2 | ANTIMICROBIAL–COATED MEDICAL ARTICLES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-12-01 | — | — | WO | disclosed |
| CN-101305406-A | Package of display optical sheet and method for packaging same | FUJIFILM CORP (JP) | 2008-11-12 | — | — | CN | disclosed |
| CN-1159798-A | Pumpable aqueous tenside concentrates | HENKEL KGAA (DE) | 1997-09-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015002-A1 | ANTIMICROBIAL COATINGS | ARG1, CAPG, CLSPN | OPRM1 4154/4885CHRNB2 4867/4885CHRNB4 4861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.